Denali Therapeutics Inc. Business Finance Contracts & Agreements
21 Contracts & Agreements
- Equity Distribution Agreements (1 contract)
- Investor Rights Agreements (1)
- Purchase Agreements (1)
- Share Agreements (1)
- Stock Agreements (12)
- Underwriting Agreements (3)
- Warrant Agreements (2)
- Form of Pre-Funded Warrant (Filed With SEC on May 7, 2024)
- Description of the Registrants Common Stock (Filed With SEC on February 28, 2024)
- Securities Purchase Agreement, dated February (Filed With SEC on February 27, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on February 27, 2024)
- Description of the Registrants Common Stock (Filed With SEC on February 27, 2023)
- Underwriting Agreement, dated as of October (Filed With SEC on October 20, 2022)
- Equity Distribution Agreement between the Company and Goldman Sachs & Co. LLC, SVB Securities LLC and Cantor Fitzgerald & Co., dated as of February 28, 2022 (Filed With SEC on February 28, 2022)
- Description of the Registrants Common Stock (Filed With SEC on February 28, 2022)
- Description of the registrants common stock (Filed With SEC on February 26, 2021)
- Standstill and Stock Restriction Agreement between the Registrant and Biogen Inc., dated September 22, 2020 (Filed With SEC on November 5, 2020)
- Common Stock Purchase Agreement between the Registrant and Biogen Inc., dated August 5, 2020 (Filed With SEC on November 5, 2020)
- Description of the registrants common stock (Filed With SEC on February 27, 2020)
- Underwriting Agreement, dated as of January 28, 2020, among Denali Therapeutics Inc. and Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, and Jefferies LLC, as representatives... (Filed With SEC on January 29, 2020)
- Share Purchase Agreement between the Registrant, certain shareholders of F-star Gamma Limited and Shareholder Representative Services LLC, dated May 30, 2018 (Filed With SEC on August 9, 2018)
- Standstill and Stock Restriction Agreement between the Registrant and Takeda Pharmaceutical Company Limited, dated February 23, 2018 (Filed With SEC on March 19, 2018)
- Common Stock Purchase Agreement between the Registrant and Takeda Pharmaceutical Company Limited, dated January 3, 2018 (Filed With SEC on March 19, 2018)
- 2017 Employee Stock Purchase Plan and form of agreement thereunder, to be in effect upon the completion of this offering (Filed With SEC on December 7, 2017)
- 2017 Employee Stock Purchase Plan and form of agreement thereunder, to be in effect upon the completion of this offering (Filed With SEC on November 27, 2017)
- Specimen common stock certificate of the Registrant (Filed With SEC on November 27, 2017)
- Form of Underwriting Agreement, including Form of Lock-up Agreement (Filed With SEC on November 27, 2017)
- Investors Rights Agreement among the Registrant and certain of its stockholders, dated May 8, 2015, as amended on June 4, 2015, July 22, 2015 and June 22, 2016 (Filed With SEC on November 13, 2017)
